CircRNA in ocular neovascular diseases: Fundamental mechanism and clinical potential
Pharmacological Research · 2023
DOI: 10.1016/j.phrs.2023.106946 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2023. Verfasst von Wenxin Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, 2nd Hospital of Jilin University, Changchun 130041, Jilin, China. Hauptthemen laut MEDLINE: Retinal Diseases, Macular Degeneration, Diabetic Retinopathy. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, 2nd Hospital of Jilin University, Changchun 130041, Jilin, China.
- Department of Ophthalmology, 2nd Hospital of Jilin University, Changchun 130041, Jilin, China; Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, C…
Zitieren
APA
Zhang, W., He, Y., & Zhang, Y. (2023). CircRNA in ocular neovascular diseases: Fundamental mechanism and clinical potential. Pharmacological Research. https://doi.org/10.1016/j.phrs.2023.106946
Vancouver
Zhang W, He Y, Zhang Y. CircRNA in ocular neovascular diseases: Fundamental mechanism and clinical potential. Pharmacological Research. 2023. doi:10.1016/j.phrs.2023.106946
BibTeX
@article{Zhang2023,
author = {Zhang, Wenxin and He, Yuxi and Zhang, Yan},
title = {CircRNA in ocular neovascular diseases: Fundamental mechanism and clinical potential},
journal = {Pharmacological Research},
year = {2023},
doi = {10.1016/j.phrs.2023.106946}
}
EUVIMED